The definitive, minute-by-minute guide to every billionaire around the globe. See who's up, who's down and who's a new member of the three-comma club.

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...